In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...
Previously, the drugs were able to be prescribed through an email chat, from questionnaires or by people sending in photos of ...
Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some patients taking weight-loss drugs lose muscle at far faster rates than those ...
A charity boss who struggled for years to shed pounds despite having undergone surgery has hailed weight-loss jabs as ...
Those too slim to be eligible for injections can no longer get prescription without seeing a doctor under new guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results